Ginsenoside-Rb1 for Ischemic Stroke: A Systematic Review and Meta-analysis of Preclinical Evidence and Possible Mechanisms.
Conclusion: Available findings demonstrated the preclinical evidence that G-Rb1 has a potential neuroprotective effect, largely through attenuating brain water content, promoting the bioactivities of neurogenesis, anti-apoptosis, anti-oxidative, anti-inflammatory, energy supplement and cerebral circulation.
PMID: 32296332 [PubMed]
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: Shi YH, Li Y, Wang Y, Xu Z, Fu H, Zheng GQ Tags: Front Pharmacol Source Type: research
More News: Brain | Clinical Trials | Databases & Libraries | Drugs & Pharmacology | Ginseng | Ischemic Stroke | Neurology | Stroke | Study